Know What's Happening in Healthcare

Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer

The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.

New Obesity Statistics Highlight Importance of Preventive Cardiology
NewsMar 16, 2026

New Obesity Statistics Highlight Importance of Preventive Cardiology

A new WalletHub analysis ranks Little Rock, Arkansas as the nation’s most overweight city, followed by McAllen, Texas and Memphis, Tennessee. The report evaluated 100 U.S. metro areas on adult and child obesity, cardiovascular health, food access and fitness, confirming...

By Cardiovascular Business
Advocates Press Agencies For Guidance On New Medicare Eligibility Restrictions For Certain Immigrants
NewsMar 16, 2026

Advocates Press Agencies For Guidance On New Medicare Eligibility Restrictions For Certain Immigrants

Advocates have warned that the Centers for Medicare & Medicaid Services (CMS) and the Social Security Administration (SSA) have not yet issued public guidance on new Medicare eligibility restrictions targeting certain immigrant groups. The restrictions, embedded in the Republican‑led reconciliation...

By Inside Health Policy
Ultrasound-Activated Nanoparticles Breach Bacterial Biofilms
NewsMar 16, 2026

Ultrasound-Activated Nanoparticles Breach Bacterial Biofilms

Scientists have engineered silica‑based nanoparticles that encapsulate rifampicin and release it only when exposed to low‑frequency ultrasound. The ultrasound both propels the particles through the protective matrix of bacterial biofilms and triggers cavitation that opens the particles, delivering the antibiotic...

By Chemical & Engineering News (ACS)
Vicarious Surgical Applies for Nasdaq Listing
NewsMar 16, 2026

Vicarious Surgical Applies for Nasdaq Listing

Vicarious Surgical announced it has filed an application to list its Class A common stock on Nasdaq, following a NYSE delisting notice earlier this month. Under new CEO Stephen From, the company has implemented cost‑cutting measures and outsourced parts of...

By MedTech Dive
ACO Leaders Say Mandatory Models Could Expand Value-Based Care, But Incentives Must Be Right
NewsMar 16, 2026

ACO Leaders Say Mandatory Models Could Expand Value-Based Care, But Incentives Must Be Right

CMS Innovation Center Director Abe Sutton signaled a push to enroll more providers in mandatory ACO payment models. In interviews, ACO executives said mandatory models could significantly expand the reach of value‑based care, but their success hinges on how CMS...

By Inside Health Policy
STAT+: Asthma Patients Suffered as GSK Pursued ‘Egregious’ Price Hikes, Senator Says
NewsMar 16, 2026

STAT+: Asthma Patients Suffered as GSK Pursued ‘Egregious’ Price Hikes, Senator Says

GlaxoSmithKline replaced its Flovent HFA and Flovent Diskus inhalers with an identical authorized‑generic version priced substantially higher. The move was designed to sidestep Medicaid rebate requirements, prompting health plans and pharmacy benefit managers to erect new access hurdles. Senator Maggie...

By STAT News — Pharma
Adult Disability Care Transition: Why Medicine Must Grow Up
BlogMar 16, 2026

Adult Disability Care Transition: Why Medicine Must Grow Up

The article warns that adults with disabilities encounter a systemic collapse when pediatric care ends, leaving them invisible to internal medicine, family practice, and psychiatry. It critiques the ethical danger of relying on AI for self‑diagnosis, arguing that technology cannot...

By KevinMD
AI and Genomics: A New Era of Personalized Medicine
NewsMar 16, 2026

AI and Genomics: A New Era of Personalized Medicine

Artificial intelligence is reshaping genomics by speeding up sequencing and uncovering patterns that traditional tools miss, enabling truly personalized medicine. AI models can predict disease risk, suggest optimal therapies, and guide tumor classification, especially in oncology and emerging mRNA vaccine...

By JD Supra – Legal Tech
Placenta Capsules Lack Benefit and Pose Infection Risk
SocialMar 16, 2026

Placenta Capsules Lack Benefit and Pose Infection Risk

I did placenta encapsulation with my first baby due to my prior midwife's recommendation, but I no longer do it or recommend it. Here's why. The only placebo-controlled trials on it (UNLV) found no meaningful benefit for mood, fatigue, bonding, or iron...

By Preethi Kasireddy
Understanding 21 CFR Part 820
NewsMar 16, 2026

Understanding 21 CFR Part 820

The FDA has rebranded 21 CFR Part 820 as the Quality Management System Regulation (QMSR), effective February 2 2026, and formally incorporated ISO 13485:2016 by reference. The revision trims the regulation to only Subparts A (General Provisions) and B (Supplemental Provisions), directing manufacturers to the ISO standard...

By Quality Digest
How Synergy Spine Engineered Its New Cervical Disc for Mobility and Alignment
NewsMar 16, 2026

How Synergy Spine Engineered Its New Cervical Disc for Mobility and Alignment

Synergy Spine Solutions secured FDA pre‑market approval for its Synergy Disc, the first artificial cervical disc that simultaneously improves spinal alignment and preserves full range of motion. The device features a patented interrupted‑articulation geometry that creates a low‑energy, lordotic position...

By Medical Design & Outsourcing
Could AI Improve Available Treatments for Geographic Atrophy?
NewsMar 16, 2026

Could AI Improve Available Treatments for Geographic Atrophy?

Geographic atrophy (GA) management is poised to benefit from AI‑driven OCT analysis, which can quantify ellipsoid zone (EZ) loss, EZ‑RPE ratio, and EZ thickness with micron‑level precision. In Europe, imaging tools like the Topcon GA Monitor are approved, while the...

By Healio
Imaging Evaluations and PCI Planning: Heartflow Announces ‘Tremendous Progress’ for AI Portfolio
NewsMar 16, 2026

Imaging Evaluations and PCI Planning: Heartflow Announces ‘Tremendous Progress’ for AI Portfolio

Heartflow announced that its AI‑enabled Plaque Analysis software will be highlighted in three ACC.26 presentations, showcasing data from a 15,000‑patient CCTA registry that predicts major adverse cardiovascular events. A separate DECIDE registry of nearly 3,800 patients demonstrated that AI‑guided care...

By Cardiovascular Business
HIMSS26: The Risks and Rewards of Agentic Artificial Intelligence
NewsMar 16, 2026

HIMSS26: The Risks and Rewards of Agentic Artificial Intelligence

At HIMSS26, healthcare leaders highlighted the promise of agentic artificial intelligence to automate routine tasks such as prior authorizations, scheduling, and patient outreach. They warned that the technology’s independent decision‑making can introduce workflow risks if left unchecked. Effective deployment hinges...

By HealthTech Magazine
CASPR Is Hiring
BlogMar 16, 2026

CASPR Is Hiring

CASPR announced three senior hires: Director of Research, Director of Policy, and Policy Lead. The research director will lead scientific collaborations, identify clinical trial opportunities, and ensure evidence‑based policy. The policy roles will advance legislative initiatives, including NIH trial funding...

By Recursive Adaptation
DRC Nears Historic 14.5% Abuja Target for Health Sovereignty
NewsMar 16, 2026

DRC Nears Historic 14.5% Abuja Target for Health Sovereignty

The Democratic Republic of Congo is rapidly reshaping its health financing by mobilising domestic resources and tightening public financial management. Core health allocations now exceed 5.5 trillion Congolese franc, while new revenue streams – a 2 % import levy and a mandatory...

By Devex – News
Prioritize Natural Fertility Solutions Before Resorting to IVF
SocialMar 16, 2026

Prioritize Natural Fertility Solutions Before Resorting to IVF

I'm not going to comment on the specific stats here because I haven't read the book yet and some of these numbers need more context. But the broader point matters. Women deserve full transparency before making a decision that costs $15-20K...

By Preethi Kasireddy
Medical Lasers Need Rare Earths for Precision Healing
BlogMar 16, 2026

Medical Lasers Need Rare Earths for Precision Healing

Medical lasers rely on rare earth elements for their core components, enabling precise wavelength-specific energy delivery that reduces bleeding and speeds recovery. Elements such as neodymium, erbium, holmium, ytterbium and yttrium are doped into laser crystals, while dysprosium, terbium and...

By Rare Earth Exchanges (REEx) – News/Insights
What Are Different Factors For Medical Alert Devices Comparison?
BlogMar 16, 2026

What Are Different Factors For Medical Alert Devices Comparison?

Choosing a medical alert device hinges on response speed, coverage, and usability. Consumers must evaluate 24/7 monitoring centers, in‑home versus mobile signal range, and the reliability of fall‑detection sensors. Design factors such as comfort, waterproofing, and battery life affect daily...

By Think Save Retire
Beyond the Hype: Subtle HIMSS Wins over Flashy Demos
SocialMar 16, 2026

Beyond the Hype: Subtle HIMSS Wins over Flashy Demos

HIMSS had a cat pit, a robot hand on someone's head, and an AI announcement from basically every vendor alive. But we liked other subtler stories: @HeyEpic soft-launching a pharmacy network product that perhaps could eventually take on @Surescripts, a...

By Brendan Keeler
Quality Care: 45‑Minute Pediatric Visit Makes All Difference
SocialMar 16, 2026

Quality Care: 45‑Minute Pediatric Visit Makes All Difference

Doctors who take their time with each patient >>>> I know it can depend on their schedule, but our pediatrician took 45 minutes with us and it was so helpful

By Lisa Mitro, DPT (Physical Therapist for Runners)
Why More U.S. Doctors Are Moving to Canada
BlogMar 16, 2026

Why More U.S. Doctors Are Moving to Canada

U.S. physicians are increasingly relocating to Canada, driven by frustration with insurance‑driven bureaucracy and high patient out‑of‑pocket costs in the United States. Recruitment firm CanAm reports a 65 % surge in inquiries during the early Trump administration, while the Medical Council...

By HEALTH CARE un-covered
Structure Therapeutics Inc. (GPCR) Discusses Positive Topline Results From ACCESS II and Related Studies of Aleniglipron Oral GLP-1 Transcript
NewsMar 16, 2026

Structure Therapeutics Inc. (GPCR) Discusses Positive Topline Results From ACCESS II and Related Studies of Aleniglipron Oral GLP-1 Transcript

Structure Therapeutics announced positive topline data from its ACCESS II trial of aleniglipron, an oral small‑molecule GLP‑1 receptor agonist. The study demonstrated statistically significant reductions in HbA1c and weight loss comparable to injectable GLP‑1 therapies. Safety signals were mild, with few...

By Seeking Alpha — Site feed
Scaling Health Tech: 6 Lessons From Launching a Second Brand
NewsMar 16, 2026

Scaling Health Tech: 6 Lessons From Launching a Second Brand

In 2022 32Co launched as a premium orthodontic aligner platform, then expanded in 2026 with Aerox Health, a dedicated sleep‑medicine brand. The company leveraged an existing dentist network to address the under‑served UK sleep‑apnoea market, applying the same clinical engine...

By Startups Magazine
CytomX Surges on Positive Data for ‘Masked’ ADC in Colorectal Cancer
NewsMar 16, 2026

CytomX Surges on Positive Data for ‘Masked’ ADC in Colorectal Cancer

CytomX Therapeutics’ shares surged 66% after the company released expansion data from its Phase 1 study of Varseta‑M, a masked antibody‑drug conjugate targeting EpCAM in late‑stage colorectal cancer. The trial evaluated three dose levels, with the two highest doses achieving response...

By BioPharma Dive
Maker of Ozempic Failed to Report Strokes, Suicidal Ideation and Deaths
BlogMar 16, 2026

Maker of Ozempic Failed to Report Strokes, Suicidal Ideation and Deaths

The FDA issued a formal warning letter to Novo Nordisk, citing serious violations for failing to report adverse events such as strokes, suicidal ideation, and patient deaths linked to its GLP‑1 drugs Ozempic, Wegovy and Saxenda. Inspectors found the company...

By The Vigilant Fox
AI's Role in Healthcare Explained in 100 Q&A
SocialMar 16, 2026

AI's Role in Healthcare Explained in 100 Q&A

Introducing "100 Questions and Answers About Artificial Intelligence in Healthcare" - your essential guide to understanding the integration of AI and medicine. - Explore 100 essential questions, each offering concise yet insightful answers supported by research and real-world examples. - From the...

By Bertalan Meskó, PhD
Medicine Needs Blended Intelligence, Not AI vs Doctors
SocialMar 16, 2026

Medicine Needs Blended Intelligence, Not AI vs Doctors

AI can read the chart. But it can’t read the room. Today a patient’s story revealed something the algorithm didn’t flag. The future of medicine isn’t AI vs doctors. It’s Blended Intelligence, or “BI.” We need both. More in the video below 👇 https://t.co/7iwPleaAJD

By Brennan Spiegel, MD
How Zinc Protects Injured Arteries From Accelerated Aging
BlogMar 16, 2026

How Zinc Protects Injured Arteries From Accelerated Aging

Researchers published in Aging Cell report that vascular injury induces misshapen nuclei in smooth muscle cells, accelerating cellular senescence. Human femoral arteries post‑angioplasty and rat carotid injury models both displayed nuclear dysmorphism linked to prelamin A buildup. The study identifies...

By SENS Research Foundation – The SENSible Blog
AI's Limited Impact on Cancer Explained
SocialMar 16, 2026

AI's Limited Impact on Cancer Explained

F Cancer Why has AI had so little impact on Cancer? New essay, link below. https://t.co/cLsoh7c7do

By Gary Marcus
FDA Urges IRB Overhaul to Match China's 60‑day Trials
SocialMar 16, 2026

FDA Urges IRB Overhaul to Match China's 60‑day Trials

FDA commissioner Makary at a CMS conference today in Baltimore calls for “big and different” IRB reforms to catch China's speedy trial starts - pre-IND phase can run 380 days in the US, he said, while China is pushing for...

By Zach Brennan
Serenity Engage
BlogMar 16, 2026

Serenity Engage

Serenity Engage, now rebranded as Serenity Connect, is a HIPAA‑compliant communication platform that links senior living communities, healthcare providers, and families. The solution consolidates messaging, photo sharing, and real‑time updates into a single concierge‑style interface, often paired with voice‑AI assistants...

By Everywhere VC
Bioethics Bureaucracy Stifles Medical Research Progress
SocialMar 16, 2026

Bioethics Bureaucracy Stifles Medical Research Progress

Medical Research Is Hopelessly Caught in Red Tape. Part of the blame goes to "bioethics," which I've long argued is highly unethical. https://t.co/6tF016elEH

By Steven Pinker, PhD
AI Excels in Detail, yet Cancer Cure Remains Distant
SocialMar 16, 2026

AI Excels in Detail, yet Cancer Cure Remains Distant

AI, strong on details, and tantalizingly close to curing cancer? Sobering to still see examples like these regularly.

By Gary Marcus
This Hidden Immune Signal Could Change Cancer Therapy
NewsMar 16, 2026

This Hidden Immune Signal Could Change Cancer Therapy

Researchers have identified that a surface‑defensive molecule on cancer cells not only sends a “don’t‑eat‑me” signal but also conceals an “eat‑me” cue that would normally trigger immune clearance. A newly engineered antibody can disrupt this masking interaction, making tumors visible...

By Forbes – Healthcare
Reengineering High-Volume Imaging Workflows with Gleamer AI
SocialMar 16, 2026

Reengineering High-Volume Imaging Workflows with Gleamer AI

« ⁦@RadNetImaging⁩ CEO Howard Berger, MD, said it has become increasingly critical to #reengineer high-volume #workflows. This is particularly pertinent in X-ray, ultrasound and mammography, where ⁦@gleamer_ai⁩ holds expertise. » 👌 🚀 https://t.co/wSqNyHlkXj

By Amine Korchi, MD
CytomX Jumps 66% on Promising Colorectal ADC Data
SocialMar 16, 2026

CytomX Jumps 66% on Promising Colorectal ADC Data

CytomX surges on positive data for ‘masked’ ADC in colorectal cancer https://t.co/PxQMISvyri by @Lilah_Alvarado $CTMX + 66%

By Ben Fidler
Missed Cancer Symptoms In Young Patients: How To Advocate For Yourself
NewsMar 16, 2026

Missed Cancer Symptoms In Young Patients: How To Advocate For Yourself

Jillian Romeo’s experience shows how young adults with cancer often face dismissed symptoms until disease advances. A 2024 analysis found 87% of adolescents and young adults had documented warning signs before diagnosis, with females waiting over three months on average....

By Forbes – Healthcare
GenAI Predicts Insulin Resistance Using Wearables and Routine Labs
SocialMar 16, 2026

GenAI Predicts Insulin Resistance Using Wearables and Routine Labs

Innovation with genAI, predicting insulin resistance from wearable device data (for steps, heart rate, sleep) integrated with demographics and routine blood parameters. Without CGM. @aametwally1 @GoogleResearch @NatureMedicine https://t.co/PRZPLGjuxZ https://t.co/ShbFyO55qP

By Eric Topol
Structure's GLP-1 Pill Shows Best-in-Class Obesity Results
SocialMar 16, 2026

Structure's GLP-1 Pill Shows Best-in-Class Obesity Results

Structure’s GLP-1 pill shows ‘best-in-class’ potential in obesity trial https://t.co/j0fzAg6GRV @ByJonGardner $GPCR $LLY $NVO $AZN $MRK #obesity

By Ben Fidler
Heart Failure Hospitalizations After PCI: A Warning Sign of ‘Exceptionally High Risk’
NewsMar 16, 2026

Heart Failure Hospitalizations After PCI: A Warning Sign of ‘Exceptionally High Risk’

A new JACC: Cardiovascular Interventions study of over 10,000 PCI patients in Japan found that heart‑failure hospitalizations occur in 4.7% of cases and are linked to a 25% two‑year mortality rate. By contrast, acute coronary syndrome and major bleeding showed...

By Cardiovascular Business
Linking U.S. Medicare Payments to Global Benchmarks Matters
SocialMar 16, 2026

Linking U.S. Medicare Payments to Global Benchmarks Matters

CMS' CMMI dir. Abe Sutton at quality conf. in Baltimore today: "tying what we pay to what other countries pay across Medicare Part B, Medicare Part D and Medicaid really matters."

By Zach Brennan
Stryker Attack Raises Concerns About Role of Device Management Tool
NewsMar 16, 2026

Stryker Attack Raises Concerns About Role of Device Management Tool

Stryker, a leading medical‑device maker, suffered a wiper attack that used Microsoft Intune to remotely erase data on thousands of phones and workstations. The Iran‑linked Handala group claimed responsibility, alleging the theft of 50 TB of data and the destruction of...

By Cybersecurity Dive (Industry Dive)
Rezūm Water Vapour Therapy Outperforms Drug Combination for BPH Symptom Relief, Trial Shows
BlogMar 16, 2026

Rezūm Water Vapour Therapy Outperforms Drug Combination for BPH Symptom Relief, Trial Shows

Boston Scientific announced that its Rezūm Water Vapour Therapy outperformed standard combination drug therapy in a 12‑month VAPEUR trial for symptomatic BPH in sexually active men. The study of 151 patients showed a 4.6‑point greater reduction in IPSS scores and...

By Health Tech World
Bimekizumab Does Not Increase Depression, Suicide Risk Vs. Other Psoriasis Biologics
NewsMar 16, 2026

Bimekizumab Does Not Increase Depression, Suicide Risk Vs. Other Psoriasis Biologics

A retrospective TriNetX analysis of 1,691 psoriasis patients compared bimekizumab with IL‑23 inhibitors and found no greater incidence of new‑onset depression, suicidal ideation, or related medication use. Over a two‑year follow‑up, the combined psychiatric event rate was 4.9% for bimekizumab...

By Healio
Herniated Disc Recovery: A Physician’s Personal Journey
BlogMar 16, 2026

Herniated Disc Recovery: A Physician’s Personal Journey

Dr. Eric Dessner, an ophthalmologist, shares his year‑long, non‑surgical recovery from a large lumbar herniated disc. He describes the biological process of disc material dehydration and phagocytic resorption, the limited benefit of physical therapy and epidural injections, and the eventual...

By KevinMD
Multi-Ancestry Polygenic Score Predicts T2D, Obesity, GLP‑1 Need
SocialMar 16, 2026

Multi-Ancestry Polygenic Score Predicts T2D, Obesity, GLP‑1 Need

A polygenic risk score that predicts Type 2 diabetes, obesity, and likelihood for requiring a GLP-1 drug. Across 6 ancestries. https://t.co/5hTVv8kqlK https://t.co/IgXhx8vFA6

By Eric Topol
Proposing Real‑Time API National Provider Directory to End Data Hide‑and‑Seek
SocialMar 16, 2026

Proposing Real‑Time API National Provider Directory to End Data Hide‑and‑Seek

The U.S. still plays “Where’s Waldo?” with provider data. @HeyEpic ’s new concept paper lays out how CMS and partners can build a real-time, API-driven national directory. 🌐 https://t.co/URsJiyAhMm #Interoperability #FHIR #HealthIT #DigitalHealth #HITSM

By Colin Hung
HTI-5 and the New Ground Rules for Health Data: What the Comment Letters Actually Say
BlogMar 16, 2026

HTI-5 and the New Ground Rules for Health Data: What the Comment Letters Actually Say

The ONC’s HTI-5 rule, released Dec. 2025, proposes removing 34 of 60 EHR certification criteria and revising several others, while overhauling information‑blocking exceptions and scaling back AI model‑card transparency. Comment letters show broad support for the certification cleanup but fierce resistance...

By Thoughts on Healthcare Markets & Tech